Eyenovia to Present at the JMP Securities 2018 Life Sciences Conference

June 11, 2018

NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics topically to the eye, today announced that Dr. Sean Ianchulev, Eyenovia’s Chief Executive Officer is scheduled to present at the JMP Securities 2018 Life Sciences Conference taking place on June 20-21, 2018 at The St. Regis New York.

Details of the presentation are below:

Event: JMP Securities 2018 Life Sciences ConferenceDate: Wednesday, June 20, 2018Time: 1:30pm ETLocation: New York, NY

A live webcast of the presentation may be accessed on the Company’s website at http://eyenoviabio.com. The webcast will be archived for 90 days following the live presentation on the Company’s website.

About EyenoviaEyenovia, Inc. (NASDAQ:EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for micro-therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of micro-therapeutics for glaucoma and other eye diseases.

Company Contact:Eyenovia Inc.John GandolfoChief Financial Officer jgandolfo@eyenoviabio.com

Investor Contact:Tram Bui / Alexander LoboThe Ruth GroupPhone: 646-536-7035/7037E-mail: tbui@theruthgroup.com / alobo@theruthgroup.com

Media Contact:The Ruth GroupKirsten Thomas508-280-6592 kthomas@theruthgroup.com

Update hourly